Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

INR 1806.5

(0.3%)

Market Cap (In INR)

4334.29 Billion

Revenue (In INR)

484.96 Billion

Net Income (In INR)

95.76 Billion

Avg. Volume

2.02 Million

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1208.55-1960.35
PE
-
EPS
-
Beta Value
0.547
ISIN
INE044A01036
CUSIP
Y8523Y158
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Dilip Shantilal Shanghvi
Employee Count
-
Website
https://www.sunpharma.com
Ipo Date
1996-01-01
Details
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.